Thursday, November 27, 2003

NAT'RAL IS BETTER MON

Synth pot takes edge off Alzheimer's angst.

Results from a Phase II, multi-center study found dronabinol, a synthetic version of the active ingredient in marijuana, reduces agitation in patients with Alzheimer's disease. In addition, the research concluded that reduced agitation may contribute to the relief of caregiver burden associated with the condition. The findings were presented at the American Society of Consultant Pharmacists' 34th annual meeting." Read the whole release...